Q3 2024 Getinge AB Earnings Call Transcript
Welcome to the Getinge Q3 report 2023. (Operator Instructions) Now I will hand the conference over to the speakers, CEO Mattias Perjos and CFO Agneta Palmér. Please go ahead.
Thank you very much, and thanks, everyone, for joining today. We can move directly to page number 2 and the key takeaways from the quarter, please.
So we look back at a quarter where we continue to see strong global market momentum for our products. Order intake growth for Getinge as a whole increased by 10 percentage points, of which organic growth amounted to 7.4%. And this is thanks to positive development in all business areas, except for life science, and it's a good geographic spread as well when it comes to the order intake.
Net sales increased by 3.5% in the quarter, where organic growth was flat to last year. Adjusted gross margin in life science and surgical workflows improved in the quarter. However, it decreased in acute care therapies and also for the group as a consequence of this,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |